Orthopedic & Musculoskeletal Therapies Committee

Aims & Scope

Mission: (Strategy, Design, and Counsel)

1. Attract and retain leading MSK leaders in basic and translational science, clinical translation, commercialization, regulation, patient education and public health into service within ISCT.
2. Guide and catalyze effective ISCT engagement with the world-wide MSK Community.

Vision: 

MSK Committee provides a diverse forum of strategic leaders in the MSK community that guides and enables ISCT to effectively engage and serve the world-wide MSK Community.

MSK Committee extends and projects the ISCT culture of scientific rigor and ethical standards education and patient care in the broad domain of cell and gene therapy targeted for treatment of musculoskeletal disease.

Tactical Operations/Charges:

• Participate in the planning of the Roundtable Programs at the ISCT Annual Meeting and ISCT Regional Meetings and the review of submitted abstracts related to orthopedics and musculoskeletal diseases
• Review the status of the MSK field and compile position papers on the relevant scientific issues that must be addressed to advance or enable cellular therapies for musculoskeletal diseases
• Catalyze Strategic Initiatives and Workgroups 
• Offer educational opportunities to Early Stage Professionals (ESP) in the MSK field
• Service as needed to ISCT Leadership (e.g. review and commentary)
  
  

Selected Publications

Proceedings of the signature series symposium "cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies - promise, facts and fantasy," international society for cellular therapies, Montreal, Canada, May 2, 2018. (Cytotherapy. Nov 2018;20(11):1381-1400).

The Committee

Chair

Oscar Lee, MD, PhD
April 2022 - Present

MacKay Memorial Hospital,
Taipei, Taiwan.

Members

Christian Jorgensen, MD, PhD
University Hospital Lapeyronie
Montpellier, France

Elana Cooper
Georgia Institute of Technology
Atlanta, United States

Diego Correa, MD, PhD
IQVIA
Miami, United States

Maroun Khoury, PhD
Cells for Cells – REGENERO
Santiago, Chile

Dimitrios Kouroupis, PhD
Miller School of Medicine, University of Miami
Miami, United States

Stephan Kuenzel, MD, PhD, MBA
Technische Universität Dresden
Dresden, Germany
ESP Leadership Development Program

Ivan Martin, PhD
University Hospital Basel
Basel, Switzerland

George Muschler, MD
Cleveland Clinic
Cleveland, United States

Iain R Murray, MBChB, MRCS, MFSEM, PhD
The University of Edinburgh
Edinburgh, United Kingdom

Albeena Nisar, MPhil, PhD
Tata Memorial Centre
Mumbai, India
ESP Leadership Development Program

Norimasa Nakamura, MD, PhD, FRCS
Osaka Health Science University
Osaka, Japan

Nicolas S. Piuzzi, MD
Cleveland Clinic
Cleveland, United States

Pamela Robey, PhD
National Institute of Dental and Craniofacial Research
Bethesda, United States

Scott Rodeo, MD
The Hospital for Special Surgery
New York, United States

Shannon Strader, DO, MS
Mayo Clinic
Byron, United States
ESP Leadership Development Program

Preston Wolfe, PhD
Arthrex
Naples, United States
ESP Leadership Development Program

Sowmya Viswanathan, PhD
University Health Network
Toronto, Canada